A platform built on proven peptides and biologics — advancing a needle-free future for the medicines that matter most.
Many of the most important medicines are peptides and biologics — locked behind a needle. We exist to change how they reach patients.
Injections create burden and treatment fatigue — and that friction quietly drives patients off therapy.
The molecules already work — what's missing is a better way for patients to take them.
Proven molecules and a fundamentally better experience for patients — exactly what we are built for.
The biology is already proven. The unmet need is delivery — and that is exactly what we solve.
Built on foundations that compound — molecule, science, platform, and team, each reinforcing the next.
We build on molecules with years of established human safety and efficacy — a foundation of proven science.
Decades spent pioneering how large, fragile molecules can be given to patients without a needle.
Built around how people actually live with chronic treatment — not around the clinic.
Principals behind multiple approved therapies and decades of delivery innovation.
Program specifics and supporting data are shared with partners and investors under confidentiality.
Principals who have already reduced the scientific, clinical, and financing risk.
Serial healthcare founder with multiple exits; has raised ~$250M across ventures.
Co-founded Nektar; "father of inhaled biologics" and systemic pulmonary peptide delivery.
Founder/CEO of Reviver and CircleOf; Cisco Distinguished Entrepreneur and NEOM Venture Studio veteran.
Physician-scientist and clinical development leader; two decades across all phases of drug development.
EndoSonics ($1B exit) and Sanderling Ventures; capital strategy and M&A.
"Father of the engineered inhalable particle"; science behind 10+ approved inhaled products.
Serial entrepreneur behind Medisol (inhalation CRDMO) and Atom Edge; built the Breatheasy smart inhaler.
Proven medicines, delivered needle-free through one inhaled platform. If that is a future you want to build, let us talk.